The Secret Ozempic Recipe Behind Novo’s Race to Boost Supplies

Michael Hallgren, the almost 7-foot-tall Dane tasked with boosting Novo Nordisk A/S’s production of the key ingredient in Ozempic, needs a car to navigate the sprawling factory complex rising on what were once fields of grain outside Kalundborg, a former fishing village of 16,000 people in central Denmark. Once Hallgren is inside—clad in a construction hat and neon vest it takes him a few minutes just to cross one of the company’s massive halls lined with two-story steel vats for drug ingredient production. The facility is scheduled to start churning out medicine next year, but Novo has said ...